Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Rare genetic disorder gives clues to autism, epilepsy, mental retardation

Rare genetic disorder gives clues to autism, epilepsy, mental retardation

September 24, 2008

Symptoms may stem from structural abnormalities in neurons that lead to excess brain connections

A rare genetic disorder called tuberous sclerosis complex (TSC) is yielding insight into a possible cause of some neurodevelopmental disorders: structural abnormalities in neurons, or brain cells. Researchers in the F.M. Kirby Neurobiology Center at Children's Hospital Boston, led by Mustafa Sahin, MD, PhD, and Xi He, PhD, also found that normal neuronal structure can potentially be restored.




If this could be done safely in humans, it might be possible to ameliorate the symptoms of epilepsy, mental retardation and autism, which are frequent complications of TSC, say the researchers. Their findings, accompanied by commentary, were the cover article of the September 15 issue of Genes & Development.

TSC causes benign tumor-like lesions, which can affect every organ in the body and are called tubers when they occur in the brain. In the study, Sahin, He, lead author Yong-Jin Choi, PhD, and colleagues show in mice that when the two genes linked to the disease, TSC1 and TSC2, are inactivated, neurons grow too many axons (the long nerve fibers that transmit signals). Normal neurons grow just one axon and multiple dendrites (short projections that receive input from other neurons). This specification of axons and dendrites, known as polarity, is crucial for proper information flow.

"We think if initial polarity is not formed properly, the result will be abnormal connectivity in the brain," says Sahin, who also directs the clinical Multi-Disciplinary Tuberous Sclerosis program at Children's.

Since autism occurs in about half of people with TSC, the findings support the idea that such miswiring causes or contributes to autism, Sahin adds. He has received funding from Autism Speaks, the Manton Foundation and the Tuberous Sclerosis Alliance to pursue this idea further.

"People have started to look at autism as a developmental disconnection syndrome - there are either too many connections or too few connections between different parts of the brain," Sahin says. "In mouse models of TSC, we're seeing an exuberance of connections."

In laboratory experiments, the researchers were able to limit multiple axon formation by using the cancer drug rapamycin to suppress production of a protein called SAD-A kinase. This protein is produced in excess when the TSC1 and TSC2 genes are inactivated, and is found in abundance in the abnormally large cells that make up tubers.

Because increased SAD-A is associated with increased axon growth, the researchers also speculate that the TSC pathway could be manipulated to regenerate or repair axons lost or damaged in spinal cord or other nerve injuries.

"These findings provide a potential explanation for neurological abnormalities in TSC patients and perhaps in people without TSC," says He. "The challenge remains as to how to treat these conditions. We have some clues but a lot more research needs to be done."

Children's Hospital Boston



Related Tuberous Sclerosis Current Events and Tuberous Sclerosis News Articles Tuberous Sclerosis Current Events and Tuberous Sclerosis News RSS Tuberous Sclerosis Current Events and Tuberous Sclerosis News RSS
The first autism disease genes
The autistic disorder was first described, more than sixty years ago, by Dr. Leo Kanner of the Johns Hopkins Hospital (USA), who created the new label 'early infantile autism'.

Drug reverses mental retardation caused by genetic disorder
UCLA researchers discovered that an FDA-approved drug reverses the brain dysfunction inflicted by a genetic disease called tuberous sclerosis complex (TSC).

Genetic breakthrough offers promise in tackling kidney tumors
A new study has shown promising results in fighting a severe genetic disorder which can create tumours throughout the body.

Transplant drug sirolimus shrinks tumors, improves lung function
The drug sirolimus, normally used to help transplant patients fight organ rejection, may eventually be used as a less invasive treatment for a tumor called angiomyolipomata in patients with who would otherwise face surgery.

Pathway links inflammation, angiogenesis and breast cancer
A well-known inflammatory protein spawns an enzyme that inactivates two tumor-suppressing genes, ultimately triggering production of new blood vessels to nourish breast cancer cells.

Researchers make progress against lung disease attacking women in childbearing years
Researchers are advancing against a rare, deadly lung disease (related to hormones) that no one had even heard of a decade ago. The disease targets only women, striking them down during their childbearing years.

Bold Three-Stage Brain Operation for Intractable Seizures Appears Promising
Sadly, none of the treatments for epilepsy-anti-seizure medications, a procedure called vagus nerve stimulation, a special diet -could quell the electrical storms in the young boy's brain.

Tiny RNA molecules fine-tune the brain's synapses
Non-coding regions of the genome - those that don't code for proteins - are now known to include important elements that regulate gene activity.

Harmful chemicals may reprogram gene response to estrogen
New research shows that exposure to harmful chemicals and drugs during critical developmental periods early in life may actually "reprogram" the way certain genes respond to the female hormone estrogen. This genetic reprogramming may determine whether people with a genetic predisposition for a disease actually develop the disease.
More Tuberous Sclerosis Current Events and Tuberous Sclerosis News Articles


The Official Patient's Sourcebook on Tuberous Sclerosis

This book has been created for patients who have decided to make education and research an integral part of the treatment process. Although it also gives information useful to doctors, caregivers and other health professionals, it tells patients where and how to look for information covering virtually all topics related to tuberous sclerosis (also Adenoma sebaceum; Bourneville disease;...



Tuberous Sclerosis Complex: From Basic Science to Clinical Phenotypes (International Review of Child Neurology (Mac Keith Press))

Correlating new genetic data and basic science regarding tuberous sclerosis, this collection covers clinical presentation; reviews history and current diagnostic criteria; and notes recent advances in neuropathology, molecular genetics and neurobiology. Tuberous sclerosis incorporates malformations characterized by disturbances in cellular differentiation and growth. It appears with a complex...



Tuberous Sclerosis Complex (Developmental Perspectives in Psychiatry)

Tuberous Sclerosis is a genetic disease characterized by lesions of the skin and central nervous system, seizures, and sometimes sever mental retardation. Infants with this disease may appear overactive, autistic, or socially impaired. Because tuberous sclerosis involves abnormal cellular differentiation, aberrant neuronal migration, and excessive cell proliferation, this thoroughly revised...

Tuberous sclerosis



21st Century Complete Medical Guide to Tuberous Sclerosis (TSC): Authoritative Government Documents, Clinical References, and Practical Information for Patients and Physicians
by PM Medical Health News

This up-to-date electronic book on CD-ROM provides the best collection available anywhere of official Federal government information and documents on the subject of tuberous sclerosis (TSC). This CD-ROM uses next-generation search technology that allows complete indexing and makes all files on the disc fully searchable. For patients, practical information is provided in clearly written patient...

Tuberous sclerosis complex: An entry from Thomson Gale's Gale Encyclopedia of Genetic Disorders, 2nd ed.
by Pamela, MS, CGC Cohen

Information on many genetic disorders, and the frequent new findings on them, has been extremely difficult to come by—until now. The “Gale Encyclopedia of Genetic Disorders” addresses the need for current, hard-to-find facts on emerging discoveries. The two-volume Encyclopedia, presented in a single alphabetical sequence, provides clear, complete information on genetic disorders, including...

Neurologic symptoms affect most tuberous sclerosis patients. (Seizure Disorder Very Common).: An article from: Pediatric News
by Helen Lippman

This digital document is an article from Pediatric News, published by International Medical News Group on June 1, 2002. The length of the article is 509 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation...

Tuberous sclerosis complex in a young woman diagnosed incidentally on the basis of pregnancy ultrasonography.(Case Report): An article from: Southern Medical Journal
by Cassandra Caprez, Anne D. Walling, Christina M. Reimer

This digital document is an article from Southern Medical Journal, published by Southern Medical Association on May 1, 2004. The length of the article is 1743 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation...

Tuberous Sclerosis and Allied Disorders: Clinical, Cellular, and Molecular Studies (Annals of the New York Academy of Sciences)
by William G. Johnson

Clinical and Genetic Investigations into Tuberous Sclerosis and Recklinghausen's Neurofibromatosis: Contribution to Elucidation of Interrelationship and Eugenics of the Syndromes. Acta Psychiatriaca et Neurologica Scandinavica Supplementum 71
by Allan Borberg

© 2008 BrightSurf.com